-       Drug Pipelines 
- April 2025
-  60 Pages 
- Global 
   From       €1431EUR$1,600USD£1,259GBP 
      €1789EUR$2,000USD£1,574GBP 
            -       Drug Pipelines 
- April 2025
-  60 Pages 
- Global 
   From       €894EUR$1,000USD£787GBP 
      €1118EUR$1,250USD£983GBP 
            -       Drug Pipelines 
- April 2025
-  60 Pages 
- Global 
   From       €1431EUR$1,600USD£1,259GBP 
      €1789EUR$2,000USD£1,574GBP 
            -       Clinical Trials 
- April 2025
-  60 Pages 
- Global 
   From       €894EUR$1,000USD£787GBP 
      €1118EUR$1,250USD£983GBP 
            -       Report 
- December 2024
-  130 Pages 
- Global 
   From       €2826EUR$3,160USD£2,486GBP 
      €3533EUR$3,950USD£3,108GBP 
           -       Report 
- May 2025
-  100 Pages 
- Global 
   From       €4383EUR$4,900USD£3,855GBP 
          From       €4383EUR$4,900USD£3,855GBP 
          -       Report 
- July 2025
-  175 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- February 2025
-  200 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
            -       Report 
- April 2025
-  141 Pages 
- Global 
   From       €2280EUR$2,549USD£2,006GBP 
      €2682EUR$2,999USD£2,360GBP 
          -       Report 
- May 2025
-  180 Pages 
- Global 
   From       €4025EUR$4,500USD£3,541GBP 
          -       Report 
- January 2025
-  183 Pages 
- Global 
   From       €4025EUR$4,500USD£3,541GBP 
          -       Report 
- November 2024
-  180 Pages 
- Global 
   From       €4025EUR$4,500USD£3,541GBP 
          -       Report 
- August 2025
-  220 Pages 
- Global 
   From       €2236EUR$2,500USD£1,967GBP 
          -       Report 
- August 2025
-  150 Pages 
- Global 
   From       €3444EUR$3,850USD£3,029GBP 
            -       Report 
- April 2025
-  150 Pages 
- Global 
   From       €3444EUR$3,850USD£3,029GBP 
      €4338EUR$4,850USD£3,816GBP 
          -       Report 
- September 2025
-  150 Pages 
- Global 
   From       €3980EUR$4,450USD£3,501GBP 
          -       Report 
- June 2025
-  150 Pages 
- Global 
   From       €2414EUR$2,699USD£2,124GBP 
          -       Report 
- June 2025
-  150 Pages 
- Global 
   From       €2414EUR$2,699USD£2,124GBP 
          -       Report 
- June 2025
-  150 Pages 
- Global 
   From       €2414EUR$2,699USD£2,124GBP 
       
       The Allergy Drugs market is a sector of the pharmaceutical industry that focuses on the development and sale of medications used to treat allergies. Allergy drugs are used to treat a wide range of conditions, including hay fever, asthma, eczema, and food allergies. These drugs can be administered orally, topically, or through injections. Commonly used allergy drugs include antihistamines, decongestants, corticosteroids, and leukotriene modifiers.
The Allergy Drugs market is highly competitive, with    many large pharmaceutical companies vying for market share. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Sanofi, Pfizer, Novartis, and Johnson & Johnson. These companies are constantly developing new drugs and treatments to meet the needs of allergy sufferers. Show Less   Read more